Skip to content

Clinical trials

Phase 1 Osteoporosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Osteoporosis Phase: Phase 1 Clear all

104 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20024
20034
20046
20053
200610
20075
20087
20095
20105
20115
20124
20135
20145
20154
20162
20173
20181
20194
20203
20211
20223
20233
20241
20254
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed80
Unknown status11
Terminated3
Withdrawn3
Not yet recruiting3
Active, not recruiting2
Recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline10
Merck Sharp & Dohme LLC7
Amgen5
Novartis5
University of Pittsburgh5
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)3
Organon and Co3
Warner Chilcott3
Addpharma Inc.2
Asahi Kasei Therapeutics Corporation2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Osteoporosis104
Osteoporosis, Postmenopausal11
Bone Diseases, Metabolic9
Endocrine System Diseases5
Musculoskeletal Diseases5
Bone Resorption3
Cardiovascular Diseases3
Fractures, Bone3
Hyperparathyroidism3
Bone Diseases2

Trials

Showing 26 to 50 of 104. Each trial links to its page on Pharma Observatory.

4 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.